Naringenin neutralises oxidative stress and nerve growth factor discrepancy in experimental diabetic neuropathy

Neurological Research

Volumn 37, Issue 10, 2015, Pages 924-933

  Al Rejaie, Salim S ^a   Aleisa, Abdulaziz M ^a   Abuohashish, Hatem M ^a,b   Parmar, Mihir Y ^a   Ola, Mohammad S ^c   Al Hosaini, Abdulaziz A ^d   Ahmed, Mohammed M ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetes; Inflammation; Naringenin; Neuropathy; Oxidative stress

Indexed keywords

CATALASE; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; NARINGENIN; NERVE GROWTH FACTOR; NITRIC OXIDE; SOMATOMEDIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; FLAVANONE DERIVATIVE; GLUCOSE BLOOD LEVEL; INSULIN; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; HISTOPATHOLOGY; LATENT PERIOD; MALE; MECHANICAL HYPERALGESIA; NONHUMAN; OXIDATIVE STRESS; PAIN THRESHOLD; RAT; TAIL FLICK TEST; WESTERN BLOTTING; ANIMAL; BLOOD; CHEMICALLY INDUCED; DIABETIC NEUROPATHIES; DISEASE MODEL; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; METABOLISM; PATHOLOGY; SCIATIC NERVE; WISTAR RAT;

ANIMALS; BLOOD GLUCOSE; CYTOKINES; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; FLAVANONES; INSULIN; MALE; NERVE GROWTH FACTOR; OXIDATIVE STRESS; PAIN THRESHOLD; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; SCIATIC NERVE; STREPTOZOCIN;

EID: 84940180255     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132815Y.0000000079     Document Type: Article

References (49)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53
2. Roa WI. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Geneva, Switzerland: WHO Document Production Services. 2006:1–46
3. Abdi S, Haruo A, Bloomstone J. Electroconvulsive therapy for neuropathic pain: a case report and literature review. Pain Physician. 2004;7:261–63
4. Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther. 2008;120:1–34
5. Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord. 2008;9:301–14
6. Zherebitskaya E, Akude E, Smith DR, Fernyhough P. Development of selective axonopathy in adult sensory neurons isolated from diabetic rats: role of glucose-induced oxidative stress. Diabetes. 2009;58:1356–64
7. Cameron NE, Cotter MA. Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes. Diabetes Res Clin Pract. 1999;45:137–46
8. Yu J, Zhang Y, Sun S, Shen J, Qiu J, Yin X, et al. Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats. Can J Physiol Pharmacol. 2006;84:579–87
9. Arora M, Kumar A, Kaundal RK, Sharma SS. Amelioration of neurological and biochemical deficits by peroxynitrite decomposition catalysts in experimental diabetic neuropathy. Eur J Pharmacol. 2008;596:77–83
10. Cui XP, Li BY, Gao HQ, Wei N, Wang WL, Lu M. Effects of grape seed proanthocyanidin extracts on peripheral nerves in streptozocin-induced diabetic rats. J Nutr Sci Vitaminol (Tokyo). 2008;54:321–28
11. Cunha JM, Jolivalt CG, Ramos KM, Gregory JA, Calcutt NA, Mizisin AP. Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors. Metabolism. 2008; 57:873–81
12. Bierhaus A, Ziegler R, Nawroth PP. Molecular mechanisms of diabetic angiopathy – clues for innovative therapeutic interventions. Horm Res.1998;50(Suppl 1):1–5
13. Tuttle KR. Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease. J Am Soc Nephrol. 2005;16:1537–38
14. Navarro-Gonzalez JF, Mora-Fernandez C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol. 2008;19:433–42
15. Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab. 2009;94:3171–82
16. Muriach M, Bosch-Morell F, Alexander G, Blomhoff R, Barcia J, Arnal E, et al. Lutein effect on retina and hippocampus of diabetic mice. Free Radic BiolMed. 2006;41:979–84
17. Tuzcu M, Baydas G. Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats. Eur J Pharmacol. 2006;537:106–10
18. Jagetia GC, Reddy TK. The grapefruit flavanone naringin protects against the radiation-induced genomic instability in the mice bone marrow: a micronucleus study. Mutat Res. 2002;519:37–48
19. Rahigude A, Bhutada P, Kaulaskar S, Aswar M, Otari K. Participation of antioxidant and cholinergic system in protective effect of naringenin against type-2 diabetes-induced memory dysfunction in rats. Neuroscience. 2012;226:62–72
20. Mulvihill EE, Assini JM, Sutherland BG, DiMattia AS, Khami M, Koppes JB, et al. Naringenin decreases progression of atherosclerosis by improving dyslipidemia in high-fat-fed low-density lipoprotein receptor-null mice. Arterioscler Thromb Vasc Biol. 2010;30:742–48
21. Shi Y, Dai J, Liu H, Li RR, Sun PL, Du Q, et al. Naringenin inhibits allergen-induced airway inflammation and airway responsiveness and inhibits NF-kappaB activity in a murine model of asthma. Can J Physiol Pharmacol. 2009;87:729–35
22. Ortiz-Andrade RR, Sánchez-Salgado JC, Navarrete- Vázquez G, Webster SP, Binnie M, García-Jiménez S, et al. Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation. Diabetes Obes Metab. 2008;10:1097–104
23. Mulvihill EE, Allister EM, Sutherland BG, Telford DE, Sawyez CG, Edwards JY, et al. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes. 2009;58:2198–210
24. Al-Rejaie SS, Abuohashish HM, Al-Enazi MM, Al-Assaf AH, Parmar MY, Ahmed MM. Protective effect of naringenin on acetic acid-induced ulcerative colitis in rats. World J Gastroenterol. 2013;19:5633–44
25. Heo HJ, Kim DO, Shin SC, Kim MJ, Kim BG, Shin DH. Effect of antioxidant flavanone, naringenin, from citrus junoson neuroprotection. J Agric Food Chem. 2004;52:1520–25
26. Hasanein P, Fazeli F. Role of naringenin in protection against diabetic hyperalgesia and tactile allodynia in male Wistar rats. J Physiol Biochem. 2014;70:997–1006
27. Sugimoto K, Rashid IB, Shoji M, Suda T, Yasujima M. Early changes in insulin receptor signaling and pain sensation in streptozotocin-induced diabetic neuropathy in rats. J Pain. 2008;9:237–45
28. Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem. 1968;25:192–205
29. Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys. 1978;186:189–95
30. Aebi H. Catalase. In: Bergmeyer HU, editor. Methods in enzymatic analysis. New York: Academic Press. 1974 674–84
31. Kamboj SS, Vasishta RK, Sandhir R. N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy. J Neurochem. 2010;112:77–91
32. AlSharari SD, Al-Rejaie SS, Abuohashish HM, Aleisa AM, Parmar MY, Ahmed MM. Ameliorative potential of morin in streptozotocin-induced neuropathic pain in rats. Trop J Pharm Res. 2014;13:1429–36
33. Annadurai T, Muralidharan AR, Joseph T, Hsu MJ, Thomas PA, Geraldine P. Antihyperglycemic and antioxidant effects of a flavanone, naringenin, in streptozotocin-nicotinamide-induced experimental diabetic rats. J Physiol Biochem. 2012;68:307–18
34. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615–25
35. Li J, Wei GH, Huang H, Lan YP, Liu B, Liu H, et al. Nerve injuryrelated autoimmunity activation leads to chronic inflammation and chronic neuropathic pain. Anesthesiology. 2013;118:416–29
36. Djordjevic A, Bursac´ B, Velicˇkovic´ N, Vasiljevic´ A, Matic´ G. The impact of different fructose loads on insulin sensitivity, inflammation, and PSA-NCAM-mediated plasticity in the hippocampus of fructose-fed male rats. Nutr Neurosci. 2015;18(2): 66–75
37. Yu DH, Ma CH, Yue ZQ, Yao X, Mao CM. Protective effect of naringenin against lipopolysaccharide-induced injury in normal human bronchial epithelium via suppression of MAPK signaling. Inflammation. 2015;38:195–204
38. Chtourou Y, Fetoui H, Jemai R, Ben Slima A, Makni M, Gdoura R. Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases- 2, 9 via inhibition of nuclear factor kappaB pathway. Eur J Pharmacol. 2015;746:96–105
39. Esmaeili MA, Alilou M. Naringenin attenuates CCl4 -induced hepatic inflammation by the activation of an Nrf2-mediated pathway in rats. Clin Exp Pharmacol Physiol. 2014;41:416–22
40. Bolajoko EB, Mossanda KS, Adeniyi F, Akinosun O, Fasanmade A, Moropane M. Antioxidant and oxidative stress status in type 2 diabetes and diabetic foot ulcer. S Afr Med J. 2008;98:614–17
41. Bonnefont-Rousselot D. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care. 2002;5:561–68
42. Halliwell B. Drug antioxidant effects. A basis for drug selection? Drugs. 1991;42:569–605
43. Guelzim N, Huneau JF, Mathe´ V, Quignard-Boulange´ A, Martin PG, Tome´ D, et al. Consequences of PPAR(alpha) invalidation on glutathione synthesis: interactions with dietary fatty acids. PPAR Res. 2011;2011:256186
44. Goldwasser J, Cohen PY, Yang E, Balaguer P, Yarmush ML, Nahmias Y. Transcriptional regulation of human and rat hepatic lipid metabolism by the grapefruit flavonoid naringenin: role of PPARalpha, PPARgamma and LXRalpha. PLoS One. 2010;5:e12399
45. Moskaug JØ, Carlsen H, Myhrstad MC, Blomhoff R. Polyphenols and glutathione synthesis regulation. Am J Clin Nutr. 2005;81:277S–83S.
46. Kannappan S, Palanisamy N, Anuradha CV. Suppression of hepatic oxidative events and regulation of eNOS expression in the liver by naringenin in fructose-administered rats. Eur J Pharmacol. 2010;645:177–84
47. Mira L, Fernandez MT, Santos M, Rocha R, Floreˆncio MH, Jennings KR. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res. 2002;36:1199–208
48. Freeman RS, Burch RL, Crowder RJ, Lomb DJ, Schoell MC, Straub JA, et al. NGF deprivation-induced gene expression: after ten years, where do we stand? Prog Brain Res. 2004;146:111–26
49. Ola MS, Aleisa AM, Al-Rejaie SS, Abuohashish HM, Parmar MY, Alhomida AS, et al. Flavonoid, morin inhibits oxidative stress, inflammation and enhances neurotrophic support in the brain of streptozotocin-induced diabetic rats. Neurol Sci. 2014;35:1003–08.